Floatz logo

DEXAMETHASONE

HTLV-1 Infection

National Cancer Institute (NCI)Small moleculePhase 1Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the HTLV-1 Infection cohort.

Asset / SponsorPhaseRating
Nivolumab
Mayo Clinic
Phase 2B
TENOFOVIR DISOPROXIL FUMARATE
Carlos Brites
Phase 2CCC
tenofovir
Carlos Brites
Phase 2CCC
Dolutegravir
Carlos Brites
Phase 2CCC
Cyclophosphamide
National Cancer Institute (NCI)
Phase 1CC

View all 10 →

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →